Cognition Therapeutics Inc (CGTX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $64.65M
Last updated: Nov 17, 2026 at 11:03 AM ET
Cognition Therapeutics Inc (CGTX) Competitors
The companies most similar to Cognition Therapeutics are Cingulate (CING), Gain Therapeutics (GANX) and Coya Therapeutics, Inc. Common Stock (COYA). By market cap, Cognition Therapeutics ranks 8th of the 13 companies on this page; Cassava Sciences (SAVA) is the largest at $114.97M.
Peer Comparison
CGTX's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Cognition Therapeutics (CGTX) | $64.65M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Cingulate Inc (CING) | $62.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Gain Therapeutics Inc (GANX) | $46.31M | N/A | N/A | 0.0% | -170.5% | -100.0% | 0.00% |
| Coya Therapeutics, Inc. Common Stock (COYA) | $73.42M | N/A | 15.0x | 0.0% | N/A | -93.4% | 0.00% |
| Neumora Therapeutics, Inc. (NMRA) | $80.59M | N/A | N/A | 0.0% | -260.5% | 0.0% | 0.00% |
| Grace Therapeutics, Inc. (GRCE) | $38.08M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Mink Therapeutics Inc (INKT) | $47.95M | N/A | 236.3x | 0.0% | N/A | 0.0% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Cassava Sciences Inc (SAVA) | $114.97M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tenaya Therapeutics Inc (TNYA) | $79.59M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tiziana Life Sciences Ltd (TLSA) | $72.53M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Tenax Therapeutics Inc (TENX) | $73.77M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| vTv Therapeutics Inc (VTVT) | $78.99M | N/A | N/A | -20.8% | N/A | 0.0% | 0.00% |
| Peer median | $72.97M | N/A | 125.6x | 0.0% | -215.5% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Cognition Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Cingulate Inc (CING) | Cingulate Inc., a clinical-stage biopharmaceutical company, is focused on developing candidate products for the treatment of neurobiological and central nervous... | CING competitors |
| Gain Therapeutics Inc (GANX) | Gain Therapeutics, Inc., a developing biotechnology company, is dedicated to developing a variety of therapies to treat diseases caused by protein misfolding. | GANX competitors |
| Coya Therapeutics, Inc. Common Stock (COYA) | Coya Therapeutics, Inc., a clinical-stage biotechnology company, develops proprietary medicinal products to modulate the function of regulatory T cells (Tregs). | COYA competitors |
| Neumora Therapeutics, Inc. (NMRA) | Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases... | NMRA competitors |
| Grace Therapeutics, Inc. (GRCE) | Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. | GRCE competitors |
| Mink Therapeutics Inc (INKT) | MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic... | INKT competitors |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| Cassava Sciences Inc (SAVA) | Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas. | |
| Tenaya Therapeutics Inc (TNYA) | Tenaya Therapeutics Inc. is a pioneering clinical-stage biotechnology firm that is revolutionizing the treatment of heart disease through its proprietary... | TNYA competitors |
| Tiziana Life Sciences Ltd (TLSA) | Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat... | |
| Tenax Therapeutics Inc (TENX) | Tenax Therapeutics, Inc., a specialty pharmaceutical company, is dedicated to identifying, developing... | TENX competitors |
| vTv Therapeutics Inc (VTVT) | vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers, develops and sells candidates for orally administered small molecule drugs to meet... | VTVT competitors |
Frequently Asked Questions About CGTX
Who are Cognition Therapeutics' main competitors?
The companies most similar to Cognition Therapeutics include Cingulate (CING), Gain Therapeutics (GANX), Coya Therapeutics, Inc. Common Stock (COYA), Neumora Therapeutics (NMRA) and Grace Therapeutics (GRCE), listed from the closest match.
Who is Cognition Therapeutics' biggest competitor?
Cassava Sciences (SAVA) is the largest of the similar companies at $114.97M; Cingulate (CING) is the closest match by business profile, size, sector and industry.
How does CGTX stock compare with its competitors?
CGTX's net margin is 0.0% against a peer median of 0.0%.
Which of Cognition Therapeutics' competitors pays a higher dividend?
Cognition Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Cognition Therapeutics bigger than its competitors?
No. Cognition Therapeutics is 8th by market cap among the 13 companies on this page; the largest is Cassava Sciences (SAVA) at $114.97M.
CGTX pages: Overview, Earnings, Forecast, Financials, Competitors